Evaluation of cytokine levels as possible predicting elements in patients with chronic lymphocytic leukemia
Open Access
- 21 November 2022
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (10) , 1364-1368
Abstract
This study aimed to assess the patterns of serum cytokines in chronic lymphocytic leukemia patients at baseline and post-chemotherapy and investigate their association with response to treatment and chronic lymphocytic leukemia prognosis. Blood samples were taken from 32 subjects at their first medical visit after being diagnosed with chronic lymphocytic leukemia and 1 year after chemotherapy. Then, levels of cytokines and blood parameters in peripheral blood were measured. Correlation analysis was used to assess the indexes before and after chemotherapy as well as at different disease stages. Most of the patients (45.80%) had stages I and III before initiation of treatment and after treatment, respectively. There were significant differences between levels of interleukin (IL)-6 (p=0.006) and IL-10 (p=0.009) before and after treatment. Notably, the difference in IL-10 levels before and after treatment was significantly higher in the advanced stages compared to that in the non-advanced stages (p=0.007). IL-6 and IL-10 were also higher in the expired patients compared to the survived cases. Cytokines such as IL-6 and IL-10 may be considered predicting factors for chronic lymphocytic leukemia prognosis.Keywords
This publication has 19 references indexed in Scilit:
- Association between Omentin Levels and Insulin Resistance in PregnancyExperimental and Clinical Endocrinology & Diabetes, 2014
- Association of interleukin-6 and interleukin-8 with poor prognosis in elderly patients with chronic lymphocytic leukemiaLeukemia & Lymphoma, 2012
- Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemiaBlood, 2011
- Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2Haematologica, 2010
- The Role of Inflammatory Cytokines in Diabetes and Its ComplicationsJournal of Periodontology, 2008
- Serum IL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin’s lymphomaJournal of Physiology and Biochemistry, 2004
- Prognostic value of plasma interleukin‐6 levels in patients with chronic lymphocytic leukemiaCancer, 2002
- Factor(s) released from irradiated B-CLL cells induce apoptosis in leukemic lymphocytesCancer Letters, 2002
- Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcomeBlood, 2001
- Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta.1993